This image presents a creative dessert scene focused on vibrant color layering and playful food transformation. On the left, ...

BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai announced today that the Biologics License Application (BLA) for ...

Dr Robert Mutumba, the head of the Aids Control Programme at the Ministry of Health, told Daily Monitor that Ugandans are ...

Pune: The Pimpri Chinchwad crime branch arrested a 24-year-old criminal on police records on the charge of selling ...

About SHINE Technologies, LLC Headquartered in Janesville, Wisconsin, SHINE is an industry leader in next-generation fusion, developing innovative fusion-based technology that combines safety, ...

A study suggests twice-yearly Yeztugo offers HIV prevention without adversely affecting gender-affirming care.

She's in bed waiting, and you can't track down where on your body that smell is coming from. Make sure you're clean for her ...

New research has shown that the the longest-acting form of injectable PrEP, known as lenacapavir, shows no adverse interactions with hormone therapy for trans patients. Lenacapavir, which is marketed ...

In a new brief report, researchers caution against repeating past mistakes in HIV prevention, as high drug prices and insurance coverage issues have slowed uptake of long-acting, bimonthly injectable ...